BioLineRx (BLRX) Minority Interest (2025)
BioLineRx's (BLRX) quarterly Minority Interest came in at $5.1 million in Q4 2025.
BioLineRx (BLRX) Minority Interest (2025) Analysis & Trends
BioLineRx's Minority Interest history runs 1 years deep, the most recent figure standing at $5.1 million for Q4 2025.
- On a quarterly basis, Minority Interest changed N/A year-over-year to $5.1 million in Q4 2025; TTM through Dec 2025 was $5.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at $5.1 million, changed N/A from the prior year.
- Minority Interest was little changed at $5.1 million in Q4 2025 per BLRX's latest filing.
- Across five years, Minority Interest topped out at $5.1 million in Q4 2025 and bottomed at $5.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | BioLineRx | 7.05 Bn | 7.06 Bn | 154,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.15 Mn |